image credit- shutterstock
Saisei Ventures, a leading venture investment firm focused on advancing Japanese biotechnology and therapeutic innovations, has announced the launch of its Executive Fellows Programme, a structured mentorship initiative designed to strengthen the next generation of biotech entrepreneurs and executives in Japan.
By pairing experienced global biotech leaders with executives from Saisei’s Japanese portfolio companies, the Executive Fellows Programme will facilitate knowledge transfer, leadership development and create a network effect of entrepreneurship, helping to bridge this gap and advance Japan’s biotechnology entrepreneur sector.
The Executive Fellows Program is a key part of Saisei Ventures’ broader mission to not only provide capital but also cultivate the leadership and strategic capabilities required to build a globally competitive biotechnology industry in Japan. Through structured, one-on-one mentorship, portfolio company leaders will gain insights into drug development strategy, business leadership, fundraising and global market expansion.
Jonathan Yeh, Managing Partner at Saisei Ventures said, “Through the Executive Fellows Programme, we aim to empower Japan’s next generation of biotech leaders with world-class mentorship, strategic guidance and a global perspective, ensuring they have the tools needed to drive innovation and build transformative companies from Japan to the global marketplace.”
